Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
A randomised trial of hepatitis B booster vaccination at the age of 13 to 15 years following infant vaccination to assess efficacy against hepatitis B infection and acute hepatitis
ISRCTN ISRCTN71271385
DOI 10.1186/ISRCTN71271385
ClinicalTrials.gov identifier
EudraCT number
Public title A randomised trial of hepatitis B booster vaccination at the age of 13 to 15 years following infant vaccination to assess efficacy against hepatitis B infection and acute hepatitis
Scientific title
Acronym GHABS
Serial number at source G0000531
Study hypothesis Added as of 23/04/2007:
A booster dose of Hepatitis B Virus (HBV) vaccine 15 years after infant vaccination will increase the magnitude and duration of immune responses (measured two and 52 weeks after the boost).
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment Gambia
Disease/condition/study domain Hepatitis B Virus
Participants - inclusion criteria Added as of 23/04/2007:
1. ID and vaccination data matched with Gambia Hepatitis Intervention Study (GHIS) database
2. Born between 1/7/1988 and 31/12/1989
3. Living in selected Health Centre (HC) catchment area's
4. Informed consent participant and parent/guardian
Participants - exclusion criteria Added as of 23/04/2007:
1. No complete informed consent
2. No match found
3. Not fully vaccinated in infancy
4. Not in age range
Anticipated start date 01/01/2004
Anticipated end date 31/12/2005
Status of trial Completed
Patient information material
Target number of participants Added as of 23/04/2007: 500
Interventions Added as of 23/04/2007:
Booster dose HBV vaccine
Primary outcome measure(s) Added as of 23/04/2007:
Anti-HBs titers after one year.
Secondary outcome measure(s) Added as of 23/04/2007:
Proportion without anamnestic response following boosting.
Sources of funding Medical Research Council (MRC) (UK)
Trial website
Publications 2007 results in http://www.ncbi.nlm.nih.gov/pubmed/17710152
Contact name Dr  Andrew J  Hall
  Address London School of Hygiene and Tropical Medicine
Keppel Street
  City/town London
  Zip/Postcode WC1E 7HT
  Country United Kingdom
Sponsor Medical Research Council (MRC) (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 21/09/2000
Last edited 02/07/2009
Date ISRCTN assigned 21/09/2000
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.